Literature DB >> 11718450

Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size.

S Tamai1, H Masuda, Y Ishii, S Suzuki, Y Kanai, H Endou.   

Abstract

The purpose of this study was to examine whether L-type amino acid transporter 1 (LAT1), one of the amino acid transporters, is related closely to tumor size in liver metastasis. Rat colon cancer cells (RCN-9) were injected into the capsule of the spleen of 12 male rats (inbred F344/DuCrj). Conversely, four rats received only phosphate-buffered saline (control group 1), and four rats underwent only laparotomy (control group 2). In each rat, the metastatic tumors, areas surrounding tumor nodules, or the livers of the control groups were immunostained with the antibodies to LAT1 C peptide antigen. In control groups 1 and 2, normal hepatocytes did not indicate a staining of LAT1. A total of 90 metastatic nodules were found in 12 livers with metastasis. Of the 90 metastatic nodules, 43 nodules indicated a positive staining of LAT1. Conversely, the remaining 47 metastatic nodules had a negative staining of LAT1. The average size in metastatic nodules in the group with positive staining of LAT1 was 1.6 +/- 0.4 mm2, which was significantly higher than that of the group with negative staining of LAT1 (0.6 +/- 0.2 mm2; P = .0007). The ratio of the average area of the metastatic nodule against the average largest section of the left lobe of the lateral segment (RML, %) was measured. The RML in the group with positive staining of LAT1 was 1.2 +/- 0.3%, whereas the RML in the group with negative staining of LAT1 was 0.4 +/- 0.1%. A significant difference was noted between the two groups (P = .0004). We concluded that LAT1 plays an important role in tumor cell growth of liver metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718450

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  6 in total

Review 1.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 2.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.

Authors:  Zhongxing Liang; Heidi T Cho; Larry Williams; Aizhi Zhu; Ke Liang; Ke Huang; Hui Wu; Chunsu Jiang; Samuel Hong; Ronald Crowe; Mark M Goodman; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

4.  Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Authors:  Kuniaki Nakanishi; Sho Ogata; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Shinsuke Aida; Hiroyasu Kasamatsu; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2007-07-11       Impact factor: 4.064

5.  Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestines.

Authors:  Chikara Ohno; Yohko Nakanishi; Taku Honma; Akihiro Henmi; Masahiko Sugitani; Yoshikatsu Kanai; Norimichi Nemoto
Journal:  Acta Histochem Cytochem       Date:  2009-05-29       Impact factor: 1.938

6.  Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.

Authors:  K Kaira; N Oriuchi; H Imai; K Shimizu; N Yanagitani; N Sunaga; T Hisada; S Tanaka; T Ishizuka; Y Kanai; H Endou; T Nakajima; M Mori
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.